首页> 外文期刊>Der Pharmacia Lettre >Synthesis, characterization and biological activities of some new acidhydrazones derived from 2-[(N-cinnamoyl) 2, 5-dichloroanilido]acetohydrazide
【24h】

Synthesis, characterization and biological activities of some new acidhydrazones derived from 2-[(N-cinnamoyl) 2, 5-dichloroanilido]acetohydrazide

机译:2-[(N-肉桂酰基)2,5-二氯苯胺基]乙酰肼衍生的一些新型acid肼的合成,表征和生物活性

获取原文
           

摘要

A series of new acid hydrazones have been synthesized by the reaction of 2-[(N-cinnamoyl) 2, 5- dichloroanilido] acetohydrazide with various Carbonyl Compounds in 42 to 88 % yield. Hydrazones are white, brown and yellow colour solids, having high melting points. Newly synthesized compounds (1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15, 16 and 17) have been tested for their antibacterial activity against gram positive bacteria S.albus, S.aureus and gram negative bacteria E.Coli and Pseudomonas piosineus .The compound 2, 3, 5, 12, 13, 14, and 15 shown significant activity and compound 1, 4, 6, 7, 8, 9, 16 and 17 have shown moderate activity. The same compounds were tested for their antifungal activity against Candida albicans, Aspergillus Niger and Alternaria alternata at concentration of 30 mg/mL using savored dextrose agar media. The compound 2, 5, 12, 13, 14, and 15 shown significant activities and compound 1, 4, 8, 9, 16 and 17 have shown moderate activity against Candida albicans and Aspergillus Niger. All the other compounds did not show significant activity against the fungi at the concentration used. Some new compounds have been tested for antitubercular activity in-vitro using Mycobacterium tuberculosis. The compounds were incorporated into Lowenstein Jensen egg medium having concentrations of 10 and 100 mg/mL and were inoculated with Mycobacterium tuberculosis, H27, Rv strains, incubated at 370C and observed, the compound 1, 3, 4, 14 inhibited the growth of Mycobacterium tuberculosis at 100mg/mL concentration other compounds were found to be inactive.
机译:通过使2-[((N-肉桂酰基)2,5-二氯苯胺基)乙酰肼]与各种羰基化合物反应,以42-88%的收率合成了一系列新的酸。 dra是白色,棕色和黄色的固体,熔点高。测试了新合成的化合物(1、2、3、4、5、6、7、8、9、12、13、14、15、16和17)对革兰氏阳性细菌S.albus,S的抗菌活性金黄色葡萄球菌和革兰氏阴性细菌大肠埃希菌和假单胞菌。化合物2、3、5、12、13、14和15表现出显着的活性,化合物1,4,6,7,8,9,16和17具有显示适度活动。使用调味的葡萄糖琼脂培养基测试了相同的化合物对浓度为30 mg / mL的白色念珠菌,尼日尔曲霉和链格孢的抗真菌活性。化合物2、5、12、13、14和15显示出显着的活性,化合物1、4、8、9、16和17显示出对白色念珠菌和尼日尔曲霉的中等活性。在所使用的浓度下,所有其他化合物均未显示出对真菌的显着活性。使用结核分枝杆菌已经测试了一些新化合物的抗结核活性。将这些化合物掺入浓度分别为10和100 mg / mL的Lowenstein Jensen卵培养基中,并接种结核分枝杆菌,H27,Rv菌株,在370°C下孵育,观察到化合物1,3,4,14抑制分枝杆菌的生长结核病在100mg / mL的浓度下没有活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号